abstract |
Disclosed is the regulation of the proprotein convertase subtilisin kexin? Compounds of the physiological role of type 9 (PCSK9), and methods of using these modulators to lower LDL-cholesterol levels and/or treat and/or prevent cardiovascular disease (CVD), including the treatment of hypercholesterolemia. |